Imported Episodic Rabies Increases Patient Demand for and Physician Delivery of Antirabies Prophylaxis

Background Imported cases threaten rabies reemergence in rabies-free areas. During 2000–2005, five dog and one human rabies cases were imported into France, a rabies-free country since 2001. The Summer 2004 event led to unprecedented media warnings by the French Public Health Director. We investigated medical practice evolution following the official elimination of rabies in 2001; impact of subsequent episodic rabies importations and national newspaper coverage on demand for and delivery of antirabies prophylaxis; regular transmission of epidemiological developments within the French Antirabies Medical Center (ARMC) network; and ARMC discussions on indications of rabies post-exposure prophylaxis (RPEP). Methodology/Principal Findings Annual data collected by the National Reference Center for Rabies NRCR (1989–2006) and the exhaustive database (2000–2005) of 56 ARMC were analyzed. Weekly numbers of patients consulting at ARMC and their RPEP- and antirabies-immunoglobulin (ARIG) prescription rates were determined. Autoregressive integrated moving-average modeling and regression with autocorrelated errors were applied to examine how 2000–2005 episodic rabies events and their related national newspaper coverage affected demand for and delivery of RPEP. A slight, continuous decline of rabies-dedicated public health facility attendance was observed from 2000 to 2004. Then, during the Summer 2004 event, patient consultations and RPEP and ARIG prescriptions increased by 84%, 19.7% and 43.4%, respectively. Moreover, elevated medical resource use persisted in 2005, despite communication efforts, without any secondary human or animal case. Conclusions Our findings demonstrated appropriate responsiveness to reemerging rabies cases and effective newspaper reporting, as no secondary case occurred. However, the ensuing demand on medical resources had immediate and long-lasting effects on rabies-related public health resources and expenses. Henceforth, when facing such an event, decision-makers must anticipate the broad impact of their media communications to counter the emerging risk on maintaining an optimal public health organization and implement a post-crisis communication strategy.

[1]  T. Lembo WHO Expert Consultation on rabies. , 2010, World Health Organization technical report series.

[2]  M. Sadkowska-Todys,et al.  Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe? , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  Philippe Buchy,et al.  A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Jonathan Dushoff,et al.  Rabies Exposures, Post-Exposure Prophylaxis and Deaths in a Region of Endemic Canine Rabies , 2008, PLoS neglected tropical diseases.

[5]  P. Brouqui,et al.  Rabies Postexposure Prophylaxis, Marseille, France, 1994–2005 , 2008, Emerging infectious diseases.

[6]  M. Meltzer,et al.  Cost effectiveness of rabies post exposure prophylaxis in the United States. , 2008, Vaccine.

[7]  Anne-Marie Nicol,et al.  Communicating the Risks of a New, Emerging Pathogen: The Case of Cryptococcus gattii , 2008, Risk analysis : an official publication of the Society for Risk Analysis.

[8]  M. Eidson,et al.  Potential cost savings with terrestrial rabies control , 2007, BMC public health.

[9]  Richard D. Smith Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management , 2006, Social Science & Medicine.

[10]  B. Toma Fox rabies in France. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  I. Capek,et al.  An imported case of canine rabies in Aquitaine: Investigation and management of the contacts at risk, August 2004-March 2005. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  G. Schwitzer,et al.  Correction: What Are the Roles and Responsibilities of the Media in Disseminating Health Information? , 2005, PLoS Medicine.

[13]  Merrill Goozner,et al.  What Are the Roles and Responsibilities of the Media in Disseminating Health Information? , 2005, PLoS medicine.

[14]  D. Floret,et al.  La rage : une maladie encore présente en France ! , 2005 .

[15]  Sheri L. Bergeron,et al.  Media Effects on Students during SARS Outbreak , 2005, Emerging infectious diseases.

[16]  T. Blanchard Rabies and other lyssavirus diseases , 2004, The Lancet.

[17]  Peter Washer,et al.  Representations of SARS in the British newspapers , 2004, Social Science & Medicine.

[18]  Nicole Huang,et al.  The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. , 2004, American journal of public health.

[19]  C. DesRoches,et al.  The public's response to severe acute respiratory syndrome in Toronto and the United States. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  G. Rezza,et al.  SARS Epidemic in the Press , 2004, Emerging infectious diseases.

[21]  E. Fèvre,et al.  Estimating the Public Health Impact of Rabies , 2004, Emerging infectious diseases.

[22]  V. Covello,et al.  Best Practices in Public Health Risk and Crisis Communication , 2003, Journal of health communication.

[23]  V. Demidov Anthrax-related panic is more dangerous than the disease. , 2002, Trends in biotechnology.

[24]  M. G. Fearneyhough Rabies postexposure prophylaxis. Human and domestic animal considerations. , 2001, The Veterinary clinics of North America. Small animal practice.

[25]  J. Marx Rabies Postexposure Prophylaxis , 2000 .

[26]  L. Verbrugge,et al.  Death makes news: the social impact of disease on newspaper coverage. , 2000, Journal of health and social behavior.

[27]  J. Childs,et al.  Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. , 2000, JAMA.

[28]  V. Freimuth,et al.  Communicating the threat of emerging infections to the public. , 2000, Emerging infectious diseases.

[29]  S. Eggener,et al.  The power of the pen: medical journalism and public awareness. , 1998, JAMA.

[30]  V. Sitprija,et al.  What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? , 1996, Vaccine.

[31]  J Blancou,et al.  Rabies in Europe. , 1992, BMJ.

[32]  L Watier,et al.  A time series construction of an alert threshold with application to S. bovismorbificans in France. , 1991, Statistics in medicine.

[33]  M. Meltzer,et al.  Rabies control in the Republic of the Philippines: benefits and costs of elimination. , 1991, Vaccine.

[34]  R. Kasperson Six propositions on public participation and their relevance for risk communication. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.

[35]  P. Young,et al.  Time series analysis, forecasting and control , 1972, IEEE Transactions on Automatic Control.

[36]  Michael D. Geurts,et al.  Time Series Analysis: Forecasting and Control , 1977 .

[37]  Y. Rotivel,et al.  Epidemiology and prophylaxis of rabies in humans in France: evaluation and perspectives of a twenty-five year surveillance programme. , 2008, Developments in biologicals.

[38]  P. Brouqui,et al.  Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. , 2008, Journal of travel medicine.

[39]  I. Capek,et al.  An imported case of canine rabies in Aquitaine: investigation and management of the contacts at risk, August 2004-March 2005. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[40]  A. Mailles,et al.  Rabies in Europe in 2005. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  Thomas V Inglesby,et al.  Anthrax 2001: observations on the medical and public health response. , 2003, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[42]  L. Watier Revue méthodologique de quelques techniques spécifiques à l'analyse des séries temporelles en épidémiologie et santé publique. , 1995 .

[43]  F. Meslin,et al.  Economics of human and canine rabies elimination: guidelines for programme orientation. , 1990, Bulletin of the World Health Organization.

[44]  Peter Schmidt,et al.  The Theory and Practice of Econometrics , 1985 .

[45]  A. Macrae Rabies vaccines. , 1970, Lancet.